Y-Intercept (Hong Kong) Ltd

Position in ADMA — Adma Biologics, Inc.

CIK 1772875 HONG KONG, K3

Position in ADMA

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$9,689,552

+$8,469,771 QoQ

Shares Held

1,075,422

+1508.1% QoQ

Ownership

0.464%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Y-Intercept (Hong Kong) Ltd holds $167,304,480 across 89 Biotechnology names. ADMA ranks #2 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	35,829	$15,999,081
2	ADMA	Adma Biologics, Inc. This page	1,075,422	$9,689,552
3	UPB	Upstream Bio, Inc.	1,000,631	$9,005,679
4	ANNX	Annexon, Inc.	1,319,913	$7,312,318
5	XENE	Xenon Pharmaceuticals Inc.	85,388	$4,965,312
6	RARE	Ultragenyx Pharmaceutical Inc.	218,354	$4,574,516
7	INCY	Incyte Corp	47,833	$4,502,041
8	BMRN	Biomarin Pharmaceutical Inc	78,338	$4,425,313

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,689,552	1,075,422	+1508.1%	Shares	Sole	2026-04-27
2025-12-31	$1,219,781	66,874	-36.5%	Shares	Sole	2026-02-13
2025-09-30	$1,543,448	105,283	+40.6%	Shares	Sole	2025-10-31
2025-06-30	$1,363,765	74,891	+107.6%	Shares	Sole	2025-08-01
2025-03-31	$715,866	36,082	+21.3%	Shares	Sole	2025-05-06
2024-12-31	$510,195	29,749	-12.6%	Shares	Sole	2025-02-04
2024-06-30	$380,734	34,055	+77.3%	Shares	Sole	2024-08-14
2023-06-30	$70,862	19,204	-60.3%	Shares	Sole	2023-08-14
2022-03-31	$88,440	48,328	+190.2%	Shares	Sole	2022-05-16
2021-06-30	$26,649	16,656	—	Shares	Sole	2021-08-26
No filing history on record for this holder in this stock.